García-Rubiño ME - Search Results

1

Covalent Immobilization of Antibodies through Tetrazine-TCO Reaction to Improve Sensitivity of ELISA Technique.

García-Maceira T, García-Maceira FI, González-Reyes JA, Torres-Sánchez LA, Aragón-Gómez AB, García-Rubiño ME, Paz-Rojas E. García-Maceira T, et al. Among authors: garcia rubino me. Biosensors (Basel). 2021 Dec 20;11(12):524. doi: 10.3390/bios11120524. Biosensors (Basel). 2021. PMID: 34940281 Free PMC article.

2

What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).

Boulaiz H, Ramos MC, Griñán-Lisón C, García-Rubiño ME, Vicente F, Marchal JA. Boulaiz H, et al. Among authors: garcia rubino me. Expert Opin Ther Pat. 2017 Dec;27(12):1319-1328. doi: 10.1080/13543776.2017.1379991. Epub 2017 Sep 21. Expert Opin Ther Pat. 2017. PMID: 28929814 Review.

3

Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.

Conejo-García A, García-Rubiño ME, Marchal JA, Núñez MC, Ramírez A, Cimino S, García MÁ, Aránega A, Gallo MA, Campos JM. Conejo-García A, et al. Eur J Med Chem. 2011 Sep;46(9):3795-801. doi: 10.1016/j.ejmech.2011.05.046. Epub 2011 May 26. Eur J Med Chem. 2011. PMID: 21645946

4

Enantiospecific synthesis of heterocycles linked to purines: different apoptosis modulation of enantiomers in breast cancer cells.

García-Rubiño ME, Conejo-García A, Núñez MC, Carrasco E, García MA, Choquesillo-Lazarte D, García-Ruiz JM, Gallo MA, Marchal JA, Campos JM. García-Rubiño ME, et al. Curr Med Chem. 2013;20(38):4924-34. doi: 10.2174/09298673113206660263. Curr Med Chem. 2013. PMID: 24059234

5

Homochiral drugs: a demanding tendency of the pharmaceutical industry.

Núñez MC, García-Rubiño ME, Conejo-García A, Cruz-López O, Kimatrai M, Gallo MA, Espinosa A, Campos JM. Núñez MC, et al. Curr Med Chem. 2009;16(16):2064-74. doi: 10.2174/092986709788682173. Curr Med Chem. 2009. PMID: 19519381 Review.

6

Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors.

Cruz-López O, Conejo-García A, Núñez MC, Kimatrai M, García-Rubiño ME, Morales F, Gómez-Pérez V, Campos JM. Cruz-López O, et al. Curr Med Chem. 2011;18(7):943-63. doi: 10.2174/092986711794940824. Curr Med Chem. 2011. PMID: 21254978 Review.

7

Two tautomeric polymorphs of 2,6-dichloropurine.

García-Rubiño ME, Choquesillo-Lazarte D, Núñez MC, Campos JM. García-Rubiño ME, et al. Acta Crystallogr C. 2011 Dec;67(Pt 12):o484-6. doi: 10.1107/S0108270111043575. Epub 2011 Nov 5. Acta Crystallogr C. 2011. PMID: 22138920

8

Imidazoles and benzimidazoles as tubulin-modulators for anti-cancer therapy.

Torres FC, García-Rubiño ME, Lozano-López C, Kawano DF, Eifler-Lima VL, von Poser GL, Campos JM. Torres FC, et al. Curr Med Chem. 2015;22(11):1312-23. doi: 10.2174/0929867322666150114164032. Curr Med Chem. 2015. PMID: 25620093 Review.

9

Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups.

González-Pérez JM, Choquesillo-Lazarte D, Domínguez-Martín A, El Bakkali H, García-Rubiño ME, Pérez-Toro I, Vílchez-Rodríguez E, Castiñeiras A, Nurchi VM, Niclós-Gutiérrez J. González-Pérez JM, et al. J Inorg Biochem. 2015 Oct;151:75-86. doi: 10.1016/j.jinorgbio.2015.05.014. Epub 2015 Jun 3. J Inorg Biochem. 2015. PMID: 26190672

10

Inhibitors of Cancer Stem Cells.

García-Rubiño ME, Lozano-López C, Campos JM. García-Rubiño ME, et al. Anticancer Agents Med Chem. 2016;16(10):1230-9. doi: 10.2174/1871520616666160330104715. Anticancer Agents Med Chem. 2016. PMID: 27025655 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page